Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Martyn Lloyd Jones"'
Autor:
Naomi T Katz, Martyn Lloyd-Jones, Lucy Demediuk, Kerry McLaughlin, Megan McKechnie, Michelle Gold
Publikováno v:
Journal of Patient Experience, Vol 9 (2022)
In Australia, high-dose sublingual buprenorphine and long-acting injectable buprenorphine are available. High-dose buprenorphine is used predominantly in the setting of opioid use disorder and has a role in chronic pain. Palliative care specialists a
Externí odkaz:
https://doaj.org/article/2d8d757bc8244f27aa6a1292128d9352
Autor:
Peter Miller, Thea Vakidis, Nicholas Taylor, Tim Baker, Julian Stella, Diana Egerton‐Warburton, Shannon Hyder, Petra Staiger, Steven J. Bowe, Jonathan Shepherd, Rachel Zordan, Andrew Walby, Martyn Lloyd Jones, David Caldicott, Daniel Barker, Michael Hall, Christopher M. Doran, Nadine Ezard, Paul Preisz, Alys Havard, Anthony Shakeshaft, Hamed Akhlaghi, Kate Kloot, Nicole Lowry, Suzanne Bumpstead
Publikováno v:
Australian and New Zealand Journal of Public Health. 46:903-909
Objectives: Alcohol is the most widely consumed psychoactive substance in Australia and the consequences of alcohol consumption have enormous personal and social impacts. This study aimed to describe the principal diagnoses of emergency department (E
Autor:
Victoria Manning, Joshua B. B. Garfield, John Reynolds, Petra K. Staiger, Hugh Piercy, Yvonne Bonomo, Martyn Lloyd‐Jones, David Jacka, Reinout W. Wiers, Antonio Verdejo‐Garcia, Dan I. Lubman
Publikováno v:
Addiction, 117(11), 2837-2846. Wiley-Blackwell
Background and aims: Approach bias modification (ApBM) targeting alcohol approach bias has been previously shown to reduce likelihood of relapse during the first 2 weeks following inpatient withdrawal treatment (IWT). We tested whether ApBM’s effec
Autor:
Helen O'Brien, Joseph Doyle, Martyn Lloyd-Jones, Paul Dietze, Rehana Di Rico, Megan McKechnie, Emma Dean, Gemma Smoker
Publikováno v:
Drug and Alcohol Review. 41:293-302
INTRODUCTION Risky drinking frequently remains undiagnosed or untreated, including in hospitalised inpatients. Using the Alcohol Use Disorders Identification Test (AUDIT), we assessed the feasibility of screening for risky drinking and whether screen
Autor:
Lucy O Attwood, Megan McKechnie, Olga Vujovic, Peter Higgs, Martyn Lloyd‐Jones, Joseph S Doyle, Andrew J Stewardson
Publikováno v:
The Medical journal of Australia. 217(2)
There has been a global increase in the burden of invasive infections in people who inject drugs (PWID). It is essential that patient-centred multidisciplinary care is provided in the management of these infections to engage PWID in care and deliver
Autor:
James Williams, Lisa Collins, Amanda Norman, Helen O’Neill, Martyn Lloyd-Jones, Edward Ogden, Yvonne Bonomo, Adam Pastor
Publikováno v:
Alcohol and alcoholism (Oxford, Oxfordshire).
Objective To undertake a double blinded randomised placebo-controlled trial to assess the efficacy of vigabatrin, a GABA-transaminase inhibitor, as a benzodiazepine sparing agent in the management of acute alcohol withdrawal syndrome in a residential
Autor:
Bernadette Ward, Carl Moller, Darryl Maybery, Bente Weimand, Mona Krause, Paul Dietze, Pamela Harvey, Rebecca Kippen, Francis McCormick, Martyn Lloyd-Jones, Andrea Reupert
Publikováno v:
Children and Youth Services Review. 139:106525
Publikováno v:
Drug and Alcohol Review
Autor:
Paul Dietze, Kate Cantwell, Rachel Zordan, Adam Straub, Peter Higgs, Jennie Hutton, Martyn Lloyd-Jones, Helen Salter
Publikováno v:
Emergency medicine Australasia : EMAReferences. 32(6)
Opioid-related harms have been increasing in Australia over the last 5 years. Patients with opioid use disorder are over-represented in ED presentations. Opioid agonist treatment is the most effective community-based treatment. Buprenorphine is consi
Publikováno v:
Australian & New Zealand Journal of Psychiatry. 51:876-885
Attention deficit hyperactivity disorder and stimulant use disorder commonly co-exist, and appropriate treatments have not been well established.To provide guidance for treatment of co-existing attention deficit hyperactivity disorder and stimulant u